Journal: eLife

Article Title: Tenotomy-induced muscle atrophy is sex-specific and independent of NFκB

doi: 10.7554/eLife.82016

Figure Lengend Snippet:

Article Snippet: Antibody , Anti-myosin heavy chain (slow, alpha-, and beta-) (mouse monoclonal) , Developmental Studies Hybridoma Bank , BA-F8 , IF (1:30).

Techniques: Generated, Plasmid Preparation, Reverse Transcription, Software, Sequencing

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: IL-32β is the most dominant isoform in HepG2+LX-2 spheroids that increases neutral fat content, and IL32 downregulation lowers neutral fat in 2D cultured hepatocytes (A) To test the effect of IL-32 administration on intracellular fat content, immortalized human hepatic cell lines HepG2 and HepaRG were cultured in 2D and incubated with human recombinant IL-32α, IL-32β or IL-32γ isoform for 48 h. Then, intracellular neutral fat content was visualized by Oil Red O staining (ORO). ORO area quantified per DAPI stained nuclei by ImageJ, showed increased intracellular neutral fat content in both (A) HepG2 (top) and HepaRG (bottom). (B) To test the effect of IL32 downregulation on intracellular fat content, 24 h after seeding, cells were transfected with scramble or IL32 siRNA and grown in regular medium without FBS (HepG2) or medium supplemented with 25 μM oleic acid (HepaRG) for an additional 48 h. The average of gene knockdown efficiency was ∼70%–75% as evaluated by real-time qPCR analyzed by the 2 −ΔΔCt method. Intracellular neutral fat content was visualized by Oil Red O staining (ORO). ORO area quantified per DAPI stained nuclei by ImageJ showed lower intracellular neutral fat content in both HepG2 (left) and HepaRG (right). Two-sided p values were calculated by the Mann-Whitney non-parametric t test. Data shown as mean ± SD in all groups for the reported number of experiments. (C) HepG2+LX-2 cells were cultured as spheroids for 96 h exposing them to medium supplemented with 1% BSA or to increasing concentrations of a mixture of fatty acids (PA + OA, 1:2). IL32 gene expression measured after exposure, demonstrated higher IL32 mRNA levels with increasing intra-spheroidal triglyceride levels. The p value was calculated by test for linear trend. Data shown as mean ± SD for the reported number of experiments. (D) Percentage of IL32 gene products versus other IL-32 isoforms was measured from RNA sequencing (RNA-seq) data and IL-32β is the most dominantly expressed IL32 isoform in our spheroid model. The p value was calculated by one-way ANOVA. OA, oleic acid; PA, palmitic acid; RU, relative unit.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Cell Culture, Incubation, Recombinant, Staining, Transfection, Knockdown, MANN-WHITNEY, Gene Expression, RNA Sequencing

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: Incubation with human recombinant IL-32β increases while IL32 downregulation lowers intracellular triglyceride content in spheroids from immortalized and human primary hepatocytes (A) HepG2+LX-2 cells were cultured as spheroids for a total of 96 h. Initially, 48 h after seeding cells the media was supplemented with 25 nM IL-32β for 48 h. (B) HepG2+LX-2 spheroids were generated by seeding cells along with negative control (SCR) siRNA or 30 nM IL32 siRNA transfection mix for downregulation for total of 96 h. (C) Primary human hepatocytes (PHH) were cultured as spheroids for a total of 7 days. Initially, 48 h after seeding the media was supplemented with 25 nM IL-32β for an additional 5 days with media replacement every 48 h. (D) PHH were cultured as spheroids along with negative control (SCR) siRNA or 30 nM IL32 siRNA transfection mix for downregulation, for a total of 7 days. For both spheroid models, cellular ATP levels (marker of viability) remained stable between the experimental groups. The average of gene knockdown efficiency was ∼70%–75% as evaluated by real-time qPCR analyzed by the 2 −ΔΔCt method, relative to beta-actin. Intracellular neutral fat content measured by Oil Red O staining and AdipoRed assay showed an increase in triglycerides content after incubation with IL-32β while IL32 downregulation lowers triglyceride levels. Two-sided p values were calculated by Mann-Whitney non-parametric t test. Data shown as mean ± SD in all groups for the reported number of experiments. RFU, relative fluorescence unit; RU, relative unit (to beta-actin); SCR, scramble siRNA; untr, untreated.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Incubation, Recombinant, Cell Culture, Generated, Negative Control, Transfection, Marker, Knockdown, Staining, MANN-WHITNEY, Fluorescence

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: IL32 downregulation lowers intracellular COL1A1, increases MMP2 levels, and lowers TIMP2 in primary di-lineage human spheroids Primary human hepatocytes and primary hepatic stellate cells, at the ratio 24:1, were seeded with negative control scramble (SCR) and IL32 siRNA, at 5,000 cells/well in ultra-low attachment 96-well U-bottom ultra-low attachment plates. Fifty percent of the total media was replenished with fresh media every 48 h. (A) After 7 days of formation, spheroids were collected and 8-μM sections were subjected to immunofluorescent staining for COL1A1. Immunofluorescence was quantified by ImageJ, normalized to number of DAPI stained nuclei. The knockdown efficiency was measured by real-time qPCR, relative to beta-actin. (B) MMP2, TIMP-1, TIMP-2, and α-SMA protein levels were measured by western blotting in the cell lysate. Calnexin was used as loading control. Representative images of protein levels are shown. For each panel, data shown as mean ± SD of the reported independent experiments. Two-sided p values were calculated by Mann-Whitney non-parametric test. COL1A1, collagen Iα1; MMP2, matrix metallopeptidase 2; TIMP1, tissue inhibitor of metalloproteinase 1; TIMP2, tissue inhibitor of metalloproteinase 2.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Negative Control, Staining, Immunofluorescence, Knockdown, Western Blot, Control, MANN-WHITNEY

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: Endogenous IL32 downregulation lowers, and incubation with recombinant IL-32 β increases, intracellular triglycerides synthesis For endogenous IL32 downregulation experiments, HepG2+LX-2 spheroids were generated by seeding cells along with negative control (SCR) siRNA or IL32 siRNA transfection mix for a total of 96 h. For IL-32β incubation experiments, initially, 48 h after seeding HepG2+LX2 cells (24:1), the media was supplemented with 25 nM IL-32β for another 48 h. In both conditions, newly synthesized triglycerides were separated by TLC and quantified by scintillation counting after incubation with 6 μCi/mL 3 H-glycerol plus 1.5 mM glycerol for 12 h. (A) Reduction in de novo triglyceride synthesis after IL-32 downregulation. (D) Increase in de novo triglyceride synthesis after 25 nM IL-32β incubation. Cells were incubated with 8.5 μCi/mL 3 H-palmitate +55 μM/L palmitic acid for 6 h, after which palmitate was precipitated with BSA and perchloric acid and quantified by scintillation counting. (B and E) Graph shows no difference in beta oxidation in both experimental groups. APOB-100 synthesis and secretion levels were measured by immunoblotting. (C) Decrease in APOB-100 in cell lysate and cell culture supernatant after IL-32 downregulation. (F) No changes in APOB-100 levels in cell lysate and culture medium, after incubation with 25 nM IL-32β. The reported number of experiments were performed independently. Representative blots are presented. For all experiments, two-sided p value was calculated by Mann-Whitney non-parametric t test. Data shown as mean ± SD. AU, arbitrary units; DPM, disintegrations per minute; TAG, triacylglycerol.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Incubation, Recombinant, Generated, Negative Control, Transfection, Synthesized, Western Blot, Cell Culture, MANN-WHITNEY

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: Differentially expressed genes reveals downregulation of key genes for lipid metabolism in HepG2+LX2 spheroids (A) Key genes of lipid metabolism differentially expressed in spheroids after IL32 downregulation as compared with scramble. (B) Top 100 differentially expressed genes after IL32 downregulation as compared with scramble. Data are presented as log2-fold change in expression and –log 10 of p values adjusted using the Benjamini and Hochberg’s approach for controlling the false discovery rate (FDR). VLDL, very low-density lipoprotein.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Expressing

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: Co-downregulation of PLA2G2A and IL32 abolished the IL-32-mediated intracellular triglycerides lowering and IL32 downregulation reduces intracellular PI levels in human primary spheroids Primary human hepatocytes were cultured as spheroids and incubated with negative control (SCR) siRNA or 30 nM IL32 , and combination of IL32 and PLA2G2A for a total of 7 days. (A) Cellular ATP levels (marker of viability) were not different within the three groups. There was an 80%^–90% reduction in mRNA levels of IL32 and PLA2G2A , relative to beta-actin. Intracellular neutral lipid content (measured by Oil Red O staining) normalized to nuclei (stained by DAPI) were lower after IL32 downregulation while the co-downregulation of PLA2G2A and IL32 abolished this reduction. (B) IL32 downregulation results in higher PLA2G2A mRNA levels measured by real-time PCR. (C) IL32 and PLA2G2A were downregulated individually or in combination in primary hepatocyte spheroids and PLA2G2A levels were measured by human PLA2G2A ELISA in the culture medium. PLA2G2A levels were higher after IL32 downregulation and lower after co-downregulation of IL32 and PLA2G2A . (D) After 2 days from seeding, hepatocyte spheroids were incubated with 10, 25, and 50 nM human recombinant IL-32β for 5 days. PLA2G2A was measured from cell culture supernatant using human PLA2G2A ELISA and we observed a dose dependent decrease in secreted PLA2G2A levels with increasing concentration of IL-32β. The p values were calculated by test for linear trend. (E) Lipid fingerprint measured by liquid chromatography- quadrupole time-of-flight-mass spectrometry demonstrated lower total PI and triglycerides (top) levels after IL32 downregulation. There was a reduction in all PI species, except 40:5 and 40:6, with the largest effect size in 38:4 (bottom). For each part, data are shown as mean ± SD of the reported independent experiments. Two-sided p values calculated with unpaired t test for n = 3 and Mann-Whitney non-parametric t test for n > 3. Cer, ceramides; CL, cardiolipins; DAG, di-acylglycerides; GalCer, galactosyl ceramides; LPC, lysophosphatidylcholine; ORO, Oil Red O; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; RFU, relative fluorescence units; RU, relative units; PC, phosphatidylcholine; SM, sphingomyelin; TAG, triacylglycerols.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Cell Culture, Incubation, Negative Control, Marker, Staining, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Recombinant, Concentration Assay, Liquid Chromatography, Mass Spectrometry, MANN-WHITNEY, Fluorescence

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet: IL-32 rs76580947 minor allele associates with lower IL-32 expression, severe liver steatosis, and lower liver non-invasive tests (A) Regional plots of association between IL32 common genetic variants (minor allele frequency of >0.01) and ALT in the European subset of UK biobank. The x axis shows the variant positions (GRCh37); the y axis shows the –log10 p values. The gray diamond represents rs76580947, with the strongest association in the plotted region (IL-32 ± 50 Kbp), for which its pairwise LD with other variants is color coded as shown on the figure. (B) The association between rs76580947 and hepatic IL-32 mRNA levels was tested in 207 individuals from the MAFALDA cohort adjusting for age, gender, percentage of coding bases (a quality control measure from the Picard toolkit), RNA Integrity Number (RIN), and five surrogate variables detected by surrogate variable analysis. Carriers of the variant have lower IL-32 mRNA levels. Data shown as violin plots and adjusted p values are reported. (C) The association between IL32 rs76580947 stratified by genotype and IL-32 plasma protein level in 365,495 European participants from UK Biobank was tested using a linear regression analysis adjusted for age, gender, body mass index, first 10 genomic principal components, and array batch. Violin plot shows the normalized Protein eXpression (NPX) values that were rank-based inverse normal transformed prior to the analysis. (D) Forest plot of association and meta-analysis for IL32 rs76580947 with steatosis in three independent cohorts: Southern Italy (N = 425), Central Italy (N = 245), and Finnish (N = 745). The plot shows protection against severe liver steatosis (steatosis absence or mild vs. severe; fixed-effect p = 0.027). The association was tested by a binary logistic regression analysis under an additive genetic model adjusted by age, gender, body mass index, and recruitment center (only for the Finnish cohort). Pooled effect estimates were calculated using inverse-variance-weighted fixed effects meta-analysis. (E) The association between IL32 rs76580947 and clinical liver fibrosis scores and APOB levels in 365,495 European participants from UK Biobank. The analysis was performed under an additive model, using linear regression adjusting for age, gender, body mass index, the first 10 genomic principal components, and array batch. All traits were rank-based inverse normal transformed prior to the analysis. CI, confidence interval.

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Expressing, Variant Assay, Control, Clinical Proteomics, Transformation Assay

Journal: Cell Reports Medicine

Article Title: IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

doi: 10.1016/j.xcrm.2023.101352

Figure Lengend Snippet:

Article Snippet: After 24 h of seeding, HepG2 and HepaRG cells were exposed to human recombinant IL32α (3040-IL; R&D Systems), IL32β (6769-IL; R&D Systems) or IL32γ (4690-IL/CF; R&D Systems) for 48 h. For HepG2+LX-2 spheroids, 48 h after seeding 25 ng/mL IL32β was supplemented along with 100μL fresh medium for an additional 48 h to make a total of 200μL.

Techniques: Recombinant, Protein Extraction, Staining, Western Blot, Reverse Transcription, Enzyme-linked Immunosorbent Assay, Transfection, Gene Expression, Fluorescence, Software, Cell Counting

Journal: Nature structural & molecular biology

Article Title: Receptor subtype discrimination using extensive shape complementary designed interfaces

doi: 10.1038/s41594-019-0224-z

Figure Lengend Snippet: DRPB_Fz8-Fz8CRD complex structure confirms computational design and paves the way for specificity tuning. a, Crystal structure of DRPB_Fz8-Fz8CRD matches the computationally designed complex. The Fz8CRD is shown by blue surface. The crystal complex DRPB_Fz8 is colored in light orange and the computational model is colored in grey. The Ala “fingers” of DRPB_Fz8 are deeply “grasping” the hydrophobic groove of Fz8CRD. b, Overall structures of DRPB_Fz8 with Fz8CRD. c, An “open-book” view showing the interacting surface on both Fz8CRD and DRPB_Fz8. The interacting surface on Fz8CRD and DRPB_Fz8 is colored in grey. d, The “palm” region of DRPB_Fz8 consists of hydrophobic residues that make van der Waals interactions with Fz8 CRD. The “fingers” region of DRPB_Fz8 is omitted to gain a clear view. e, The “wrist” region of DRPB_Fz8 consists of hydrophilic and charged residues that contribute to both solubility and receptor recognition. The DRPB_Fz8 Asn112 and Arg145 form hydrogen bonds and salt bridges with Glu76 of Fz8CRD, shown as grey dashed lines.

Article Snippet: The CRDs of human FZ1 (residues 113–182), FZ4 (residues 42–161), FZ7 (residues 36–163) and FZ8 (residues 32–150 with N49Q mutation) used for crystallization contained a C-terminal 6X His tag were expressed in High Five ( Trichoplusia ni ) cells (Invitrogen) using the baculovirus expression system.

Techniques: Solubility

Journal: Nature structural & molecular biology

Article Title: Receptor subtype discrimination using extensive shape complementary designed interfaces

doi: 10.1038/s41594-019-0224-z

Figure Lengend Snippet: Complex structures of DRPB-Fz explain Fz subtype specificity. a, Titration of DPRB_Fz7/8 to biotinylated Fz 1/2/4/5/7/8 CRDs. DPRB_Fz8 was expressed on yeast surface. Biotinylated Fz 1/2/4/5/7/8 was added at gradient concentration. Alexa Fluor® 647 streptavidin was subsequently added and the median fluorescence intensity (MFI) was analyzed and plotted in Prism 7. DPRB_Fz7/8 showed EC 50 of 19.0, 31.6 and 5.6 nM to Fz1, 2 and 7. DPRB_Fz7/8 showed weaker staining to Fz5/8 with EC 50 not available. Representative Ala111Asp mutation from DPRB_Fz8 to DPRB_Fz7/8 allows hydrogen bond and salt bridge formation between DPRB_Fz7/8 with Fz7 Lys91, shown by grey dashed lines. DPRB_Fz7/8 is colored in pale cyan. Fz7CRD is colored in pink and Fz8CRD is colored in slate. The corresponding position of Lys91 is Glu, weakening DPRB_Fz7/8 interaction with Fz8 subtype. b, DPRB_Fz7 showed strong binding to Fz1, 2 and 7, respectively. DPRB_Fz7 showed no cross-reactivity to Fz5/8 up to 1 uM concentration ( , ). The Ala108Asp mutation from DPRB_Fz7/8 to DPRB_Fz7 leads to steric clashes with Trp73 of Fz8 CRD. On the other hand, the corresponding position of Fz7 subtype is Tyr, whose less bulky sidechain allows it take a different rotamer conformation. This Ala108Asp mutation thus further confers specificity to Fz7 subtype by eliminating Fz8 binding. DPRB_Fz7/8 here is colored in light cyan while DPRB_Fz7 is colored in cyan. c, DPRB_Fz4 only binds to Fz4 with EC 50 of 1.6 nM. DPRB_Fz4-Fz4CRD showed backbone movement compared with DPRB_Fz8-Fz8CRD. Therefore, DPRB_Fz4 and Fz4CRD were individually superpositioned with DPRB_Fz8 and Fz8CRD. The differences between DPRB_Fz4 and DPRB_Fz8 surface lead to less favorable interactions between DPRB_Fz4 with Fz8. For examples, Asp133Gly, Phe141Ile and Trp144Phe weaken interactions to Fz8CRD due to less bulky sidechains. The yeast titration experiements were repeated once with similar results.

Article Snippet: The CRDs of human FZ1 (residues 113–182), FZ4 (residues 42–161), FZ7 (residues 36–163) and FZ8 (residues 32–150 with N49Q mutation) used for crystallization contained a C-terminal 6X His tag were expressed in High Five ( Trichoplusia ni ) cells (Invitrogen) using the baculovirus expression system.

Techniques: Titration, Concentration Assay, Fluorescence, Staining, Mutagenesis, Binding Assay

Journal: Nature structural & molecular biology

Article Title: Receptor subtype discrimination using extensive shape complementary designed interfaces

doi: 10.1038/s41594-019-0224-z

Figure Lengend Snippet: Data collection and refinement statistics (molecular replacement)

Article Snippet: The CRDs of human FZ1 (residues 113–182), FZ4 (residues 42–161), FZ7 (residues 36–163) and FZ8 (residues 32–150 with N49Q mutation) used for crystallization contained a C-terminal 6X His tag were expressed in High Five ( Trichoplusia ni ) cells (Invitrogen) using the baculovirus expression system.

Techniques:

Journal: Nature structural & molecular biology

Article Title: Receptor subtype discrimination using extensive shape complementary designed interfaces

doi: 10.1038/s41594-019-0224-z

Figure Lengend Snippet: Fz-subtype specific DRPB antagonists inhibit homeostasis of the intestinal crypt stem cell compartment and expression of liver Wnt target genes. a, Mouse (top) and human (bottom) primary duodenal organoids which endogenously produce Wnt were cultured in submerged Matrigel in medium containing ENR (EGF/Noggin/R-spondin) with different Fz-subtype-specific DRPB antagonist at 100 nM. The images were taken at day 7 (mouse) or day 10 (human) of continuous DRPB antagonist exposure. Each Fz antagonist was replenished every 3 days during medium change. In vitro experiments were repeated at least three times, and representative images are shown. b, In vivo phenotype following daily intravenous (i.v.) injections of recombinant MSA-DRPB_Fz8 at a concentration of 20mg/kg or PBS for 7 days. H & E staining of jejunum is shown. The experiment was performed once due to limited protein yield. c-d, Representative images of H & E staining of jejunum cross-sections ( c) and glutamine synthetase (GLUL, pericentral marker) immunofluorescence staining of livers ( d) from mice that received adenoviruses expressing negative control IgG2a Fc (Fc) or different Fz-subtype-specific DRPB antagonist, 7 days post adenovirus injection (representative images from n=6 to n=9 mice/group. Experiments were repeated twice). e, Quantification of the GLUL immunofluorescence signal intensity shown in (D). f-g, Quantification of the Glul (f) and Axin2 (g) transcript levels relative to GAPDH from liver samples ( d ) by qRT-PCR. Statistical analysis was performed using GraphPad Prism software. Data represent mean ± s.e.m. (n=9; control and n=6; other groups biological replicates from 2 experiments; for all in vivo experiments (panels c-g)) Two-sided P-values were calculated by Dunn’s test of multiple comparisons following Kruskal-Wallis test. *P < 0.05; **P < 0.01; ****P < 0.0001.

Article Snippet: The CRDs of human FZ1 (residues 113–182), FZ4 (residues 42–161), FZ7 (residues 36–163) and FZ8 (residues 32–150 with N49Q mutation) used for crystallization contained a C-terminal 6X His tag were expressed in High Five ( Trichoplusia ni ) cells (Invitrogen) using the baculovirus expression system.

Techniques: Expressing, Cell Culture, In Vitro, In Vivo, Recombinant, Concentration Assay, Staining, Marker, Immunofluorescence, Negative Control, Injection, Quantitative RT-PCR, Software, Control

Journal: Neuron

Article Title: Genome-wide in vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity

doi: 10.1016/j.neuron.2020.01.004

Figure Lengend Snippet: Key Resources Table:

Article Snippet: Taqman gene expression Human PPP1R1B ( DARPP-32 ) Hs00259967_m1 , ThermoFisher , CAT#4331182.

Techniques: Virus, Genome Wide, shRNA, Control, Sequencing, Recombinant, Expressing, Multiplex Assay, Software

Journal: Frontiers in Genetics

Article Title: Human-Derived Corneal Epithelial Cells Expressing Cell Cycle Regulators as a New Resource for in vitro Ocular Toxicity Testing

doi: 10.3389/fgene.2019.00587

Figure Lengend Snippet: Detection of introduced proteins with western blotting. (A) Primary, K4D, and K4DT+T cells were applied into the western blotting using anti-CDK4, anti-Cyclin D1, anti-tubulin antibodies. The triplicated technical replicates were examined. (B) Quantitation results of the signal intensity with Image J software. The signal intensity of primary, K4D, and K4DT cells were shown in the graphs.

Article Snippet: The protein expression levels of CDK4 and Cyclin D were detected by Western blotting using an anti-CDK4 antibody (1/2,500 dilution, MBL, Nagoya, Japan; cat. no. 25955-11), an anti-cyclin D antibody (1/5,000 dilution, MB; cat. no. 553), and an anti-alpha-tubulin antibody (1/1,000 dilution, Santa Cruz Biotechnology, Dallas, TX, USA; cat. no. sc-32,293).

Techniques: Western Blot, Quantitation Assay, Software